In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharming Group NV

www.pharming.com

Latest From Pharming Group NV

Pharming Explores Further Uses For Ruconest

Pre-eclampsia and nephropathy associated with the use of contrast media in cardiac patients are two new potential uses for Pharming’s marketed C1-esterase inhibitor product.

 

Immune Disorders Clinical Trials

Wanted: Orphan Drugs, Antivirals Dominate China's Latest Fast Track List

Half of the newly selected imported drugs slated for fast track review in China are rare disease treatments, followed by antiviral drugs for influenza and HIV, reflecting key medical needs in the country.

Rare Diseases Review Pathway

Profitable Pharming Expands Ruconest Potential And Resurrects Pompe Pipeline

Dutch rare disease company Pharming talked to Scrip about turning a profit for the first time in the company’s history, finally restocking the pipeline in potentially blockbuster indications, and turning its attention back to Pompe disease after 20 years in the cold.

Rare Diseases Companies

Keeping Track: An Approval For Ajovy, A CRL For Ruconest, And Some Submissions from J&J

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
    • Synthesis Technologies, Production Processes
    • Transgenics
  • Pharmaceuticals
    • Nutraceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cardiovascular
  • Renal System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • Pharming Group NV
  • Senior Management
  • Sijmen de Vries, MD, CEO
    Robin Wright, CFO
  • Contact Info
  • Pharming Group NV
    Phone: (31) 71 5247 400
    Darwinweg 24
    P.O. Box 451 CR Leiden, 2333
    Netherlands
Advertisement
Advertisement
UsernamePublicRestriction

Register